
james@somx.health
For verified host and producer emails, sign up to view.
Episodes: 465
Frequency: Weekly
Rating: 4.4/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: United Kingdom
Instagram: 760 followers
james@somx.health
For verified host and producer emails, sign up to view.
Dr James Somauroo - Hosted by Dr James Somauroo. The show covers the latest in health and technology through interviews with disruptive healthtech startups and leaders.
Shravan Nageswaran - Diagnostic AI, Clinical Reasoning, AI Safety, Reinforcement Learning Over Medical Knowledge Graphs
Cate Lawrence - European Healthtech Journalism, Startup Coverage Criteria, Clinical Impact Vs Innovation, Data Gap And Digital Sovereignty
Ben Finlay - Depression Diagnosis, Objective Mood Measurement, Biomarkers, Mental Health Science, Direction Of Pharma/policy/ai
#453: Why "can AI replace doctors?" is the wrong question. Shravan Nageswaran, Atman Labs
July 01, 2026
This week, James is joined by Shravan Nageswaran, co-founder and CEO of Atman Labs, the London applied-AI research company building diagnostic AI that reasons like a doctor — without relying on large language models. They dig into why LLMs fall short on real clinical reasoning, what "safety" actually means when a system takes a patient history, and how reinforcement learning over a medical knowledge graph could reshape primary care. A genuinely different take on the "can AI be a doctor?" ques...
#452: Uncovering the objective truth in health tech journalism
June 24, 2026
In this episode, James is joined by Cate Lawrence, Senior Journalist at Tech.eu, to explore what the European healthtech ecosystem actually looks like from the press box, how stories get chosen, what makes a startup worth covering, and why the data gap between innovation and clinical impact remains so wide. Cate brings a decade of cross-sector reporting to the conversation, from wearable tech and women's health data to Ukrainian healthtech and the growing push for European digital sovereignty...
#451: A new biomarker for depression?
June 17, 2026
This week, James is joined by Ben Finlay, Partner at Stratt and Advisor to Ranvier.ai, to dig into why mental health is still diagnosed by questionnaire - and what a taste test, a blood biomarker and a continuum view of neurological wellness could change. Ben shares the science behind Ranvier's objective mood measurement, the journey from early intervention in depression through to staving off Alzheimer's and Parkinson's, and a candid look at where pharma, policy and AI are heading next.Conne...
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings